期刊
ARCHIVES OF PHARMACAL RESEARCH
卷 46, 期 6, 页码 500-534出版社
PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-023-01452-3
关键词
cGAS; STING; DNA; immunity; Inflammation; Cancer
cGAS is a DNA sensor that triggers a strong immune response, and its signaling pathway plays important roles in autoimmunity, inflammation, and cancer progression, making it an attractive therapeutic target. This review provides insights into the prevention and treatment of cGAS-related chronic immune and inflammatory diseases based on accumulated evidence.
Cyclic guanosine monophosphate-adenosine monophosphate (cGAMP) synthase (cGAS) is a DNA sensor that elicits a robust type I interferon response by recognizing ubiquitous danger-associated molecules. The cGAS/stimulator of interferon genes (cGAS/STING) is activated by endogenous DNA, including DNA released from mitochondria and extranuclear chromatin, as well as exogenous DNA derived from pathogenic microorganisms. cGAS/STING is positioned as a key axis of autoimmunity, the inflammatory response, and cancer progression, suggesting that the cGAS/STING signaling pathway represents an efficient therapeutic target. Based on the accumulated evidence, we present insights into the prevention and treatment of cGAS/STING-related chronic immune and inflammatory diseases. This review presents the current state of clinical and nonclinical development of modulators targeting cGAS/STING, providing useful information on the design of therapeutic strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据